BIO.News Newsletter

New data uncovers the cause of last year’s measles outbreak among children in Ohio—plus, the latest news on the Farm Bill as the September deadline looms. (524 words, 2 minutes, 37 seconds)

A new study explores links between air pollution and premature deaths from antimicrobial resistance (AMR), and over the past month, extreme weather has devastated tomato crops in India. Biotech could provide solutions to both challenges. (586 words, 2 minutes, 55 seconds)

Today, we’re looking at a flurry of new approvals and announcements—signs of the potential of biotech to solve our greatest health challenges, if policy doesn’t thwart the progress. Plus, valley fever is looking bad in California—rain and a fungus are to blame. (507 words, 2 minutes, 32 seconds)

This week is off to a busy start, with the House introducing bills to strengthen the Vaccine Injury Compensation Program, Colorado’s PDAB taking action, and an important discussion on AMR and amputees. (834 words, 4 minutes, 10 seconds)

A busy news Friday: CDC advisors voted to recommend the routine use of the first approved monoclonal antibody for RSV in infants, and a new poll shows voters like agricultural biotech and want faster regulatory approvals. (528 words, 2 minutes, 38 seconds)

We have profiles of three cancer innovators—and why it matters in the context of recent policy developments. Plus, the Pantheon Awards are accepting nominations until August 11 and NIH announced Dr. Fauci’s successor. (476 words, 2 minutes, 22 seconds)

BIO recently submitted comments to the U.S. Senate on the 340B program—here’s what we said, plus a recap of a successful BIO Asia-Taiwan. (406 words, 2 minutes, 1 second)

Happy August. BIO’s Dr. Hans Sauer explains exactly who funds biotech R&D, and a tick-borne allergy is on the rise as temperatures change ticks’ habits. (653 words, 3 minutes, 15 seconds)

BIO Chair Dr. Ted W. Love has a must-read op-ed on how recent policy actions would have kept patients from accessing his breakthrough sickle cell treatment. Speaking of policy, the EU has proposed new compulsory licensing rules—we have BIO’s take. (550 words, 2 minutes, 45 seconds)

Ending the week with the role of biotech in national security and curing hepatitis, plus more reading and listening for this hot summer weekend. (521 words, 2 minutes, 36 seconds)